Company: PFSA
Filing Date: 2025-08-25
Form Type: 424B3
Source: 0001213900-25-080387
Chunk: 143

Company: Profusa, Inc.
Filing Date: 2025-08-25
Form: 424B3
Chunk 143
---
: A.Reflects the reclassification of the remaining shares of NorthView Common Stock to permanent equity immediately prior to the Merger. B.Reflects the liquidation and reclassification of the balance of investments held in the trust account to cash and cash equivalents that becomes available to fund the Transaction. This is the full trust account balance as of June30, 2025, which is further adjusted for redemptions reflected in adjustment (P) below to reflect the remaining trust account balance following such redemptions which were distributed at closing. C. Reflects the gross proceeds from the issuance and sale of PIPE Convertible Notes of NorthView that are convertible into shares of NorthView common stock at $10.00 per share pursuant to the PIPE Subscription Agreement entered into with the PIPE Investors, assuming no redemptions. The PIPE Subscription Agreement provides for a total facility up to $22.22 million which is split into tranches. The Initial Note was funded upon closing the merger for $10 million which was subject to a 10% OID ($9.0 million net). 90 A subsequent $2.22million subject to a 10% OID ($2.0million net) is considered probable based on the terms of the convertible note. The notes did not convert as of the closing date. As such, the notes will remain in the pro forma balance sheet for pro forma purposes, as the notes convert at the election of the note holder until the shares are registered. D.Reflects the recapitalization and elimination of Northview’s pre -mergeraccumulated deficit balance. E.Represents direct and incremental transaction costs incurred by New Profusa related to the Merger and PIPE Subscription Agreement of approximately $6.0 million for advisory, banking, printing, legal and accounting that are incurred and anticipated to be incurred. These costs will not affect the Company’s combined statements of operations and comprehensive loss beyond 12 months after the acquisition date. F.Represents the payment of estimated direct and incremental transaction costs that are incurred and anticipated to be incurred, of which $1.8 million is expected to be paid in shares and $4.2 million is expected to be paid in cash, including the Business Combination Marketing Fee of $2.0 million. These costs will not affect the Company’s combined statements of operations and comprehensive loss beyond 12 months after the acquisition date. G.Represents reclassification of Profusa’s deferred offering costs to permanent equity and payment of the respective accrued and unpaid portion of the deferred offering costs.